Table 4 Intraoperative profiles and postoperative consumption of dezocine
Variables | Control group (n = 24) | Ropivacaine group (n = 23) | Low DEX + ropivacaine group (n = 24) | Medium DEX + ropivacaine group (n = 25) | High DEX + ropivacaine group (n = 24) | P value |
|---|---|---|---|---|---|---|
Propofol dosage (mg) | 328 ± 45 | 297 ± 34 | 283 ± 28 | 296 ± 33 | 295 ± 30 | 0.021 |
Remifentanil dosage (mg) | 0.95 ± 0.17 | 0.80 ± 0.26 | 0.70 ± 0.17 | 0.72 ± 0.16 | 0.73 ± 0.18 | 0.001 |
Atropine (mg) | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.03 ± 0.10 | 0.19 ± 0.10 | 0.000 |
Ephedrine (mg) | 0.24 ± 1.20 | 0.24 ± 1.20 | 0.48 ± 1.66 | 0.46 ± 1.63 | 1.00 ± 1.28 | 0.482 |
Aawakeness duration (min) | 11 ± 4 | 12 ± 6 | 11 ± 4 | 12 ± 5 | 11 ± 7 | 0.651 |
Incidences of bradycardia (n, %) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (4%) | 8 (32%) | 0.001 |
Dezocine dosage (mg) | 8.8 ± 2.3 | 7.9 ± 2.1 | 6.5 ± 1.9 | 3.8 ± 1.7 | 3.7 ± 2.0 | 0.032 |